Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04593667 · ClinicalTrials.gov registry record · NA

Randomized Study of Accelerated Radial Arterial Hemostasis

A NA study of Hemostasis, sponsored by Medcura.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04593667: Completed NA study of Hemostasis, sponsored by Medcura.

NCT04593667 is a NA study of Hemostasis that has completed, run by Medcura. The registered enrollment target is 60 participants, below the 389-participant average among 7 other Hemostasis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04593667, a NA study of Hemostasis, has completed, sponsored by Medcura.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Clinical randomized study to evaluate the effect of using a hydrophobically modified polysaccharide (hm-P) bandage

Primary Outcome

Significant change in time to hemostasis

Conditions Studied

Interventions

  • DEVICE hm-P bandage

Study Locations (1)

New York

  • Lenox Hill Hospital - Northwell Health - New York

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-11-09
Est. Completion 2021-07-14
Phase NA
Medcura

1 total trials

What the finished NCT04593667 record still lists

NCT04593667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 389-participant average among 7 other Hemostasis trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Hemostasis appearing as the primary indexed condition, and to 1 intervention - of which hm-P bandage is the first listed.

NCT04593667 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04593667 about?

NCT04593667 is a clinical study titled "Randomized Study of Accelerated Radial Arterial Hemostasis". Clinical randomized study to evaluate the effect of using a hydrophobically modified polysaccharide (hm-P) bandage

What is the current status of trial NCT04593667?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-11-09. Estimated completion is 2021-07-14.

What conditions does trial NCT04593667 study?

This clinical trial studies the following conditions: Hemostasis.

What interventions are being tested in trial NCT04593667?

The interventions under investigation include: hm-P bandage (DEVICE).

Who is sponsoring clinical trial NCT04593667?

This trial is sponsored by Medcura, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04593667 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hemostasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04593667, the US trial registry maintained by the National Library of Medicine. NCT04593667 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.